RETRACTED: Graphene oxide/zinc ferrite nanocomposite loaded with doxorubicin as a potential theranostic mediu in cancer therapy and magnetic resonance imaging
This record is marked as retracted by the source. Review the publisher’s notice before using its findings.
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (67)
Show source-provided references
1. Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics10.1002/smll.201100436 ↗
2. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery10.1002/anie.200802469 ↗
3. Inorganic nanoparticles for MRI contrast agents10.1002/adma.200802366 ↗
4. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging10.1038/nm1467 ↗
5. Cancer theranostics: the rise of targeted magnetic nanoparticles10.1016/j.tibtech.2011.03.001 ↗
6. Evaluations of structural, magnetic and various dielectric parameters of Ni-substituted Zn2W-type hexagonal ferrites for high frequency (1–6 GHz) applications10.1016/j.ceramint.2019.08.129 ↗
7. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging10.1007/s12274-012-0200-y ↗
8. Preparation of graphene intercalated magnesium silicate for enhancing the thermal stability and thermal conductivity of ethylene-vinyl acetate copolymer10.1016/j.polymer.2020.122332 ↗
9. Precisely tuning the contrast properties of ZnxFe3–xO4 nanoparticles in magnetic resonance imaging by controlling their doping content and size10.1021/acs.chemmater.9b01582 ↗
10. Zinc ferrite nanoparticle-induced cytotoxicity and oxidative stress in different human cells10.1186/s13578-015-0046-6 ↗
11. Dual drug conjugated nanoparticle for simultaneous targeting of mitochondria and nucleus in cancer cells10.1021/am5090226 ↗
12. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer10.1016/j.biomaterials.2013.01.078 ↗
13. Cyclic RGD-modified chitosan/graphene oxide polymers for drug delivery and cellular imaging10.1016/j.colsurfb.2014.07.018 ↗
14. N-doped Graphene/ZnFe2O4: a novel nanocomposite for intrinsic peroxidase based sensing of H2O210.1016/j.materresbull.2017.06.033 ↗
15. Preparation of graphitic oxide10.1021/ja01539a017 ↗
16. Biocompatible properties of nano-drug carriers using TiO2-Au embedded on multiwall carbon nanotubes for targeted drug delivery10.1016/j.msec.2018.04.094 ↗
17. Steric stabilization of β-cyclodextrin functionalized graphene oxide by host-guest chemistry: a versatile supramolecule for dual-stimuli responsive cellular delivery of doxorubicin10.1016/j.jddst.2021.102536 ↗
18. Induction of apoptosis of cancer cells using the cisplatin delivery based electrospray (CDES) system10.3390/app11073203 ↗
19. Advances in drug delivery nanosystems using graphene-based materials and carbon nanotubes10.3390/ma14051059 ↗
20. Dye removal from water by zinc ferrite-graphene oxide nanocomposite
21. Aptamer–conjugated graphene oxide–gold nanocomposites for targeted chemo-photothermal therapy of cancer cells10.1039/C5TB00134J ↗
22. Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance10.1002/adhm.201300549 ↗
23. Adsorption properties of doxorubicin hydrochloride onto graphene oxide: equilibrium, kinetic and thermodynamic studies10.3390/ma6052026 ↗
24. ZnFe 2 O 4 nanoparticles dispersed in a highly porous silica aerogel matrix: a magnetic study10.1039/c3cp54291b ↗
25. Zinc ferrite spinel-graphene in magneto-photothermal therapy of cancer10.1039/c3tb21834a ↗
26. Graphene production via electrochemical reduction of graphene oxide: synthesis and characterisation10.1016/j.cej.2014.04.004 ↗
27. A green route to prepare graphite oxide–poly(acrylic acid) and –poly(acrylamide) hybrids under γ-ray irradiation10.1016/j.matlet.2011.10.088 ↗
28. Graphene–NHC–iridium hybrid catalysts built through –OH covalent linkage10.1016/j.carbon.2014.11.016 ↗
29. FT-IR, Raman, RRS measurements and DFT calculation for doxorubicin10.1002/jemt.20849 ↗
30. Photoluminesence and FTIR study of ZnO nanoparticles: the impurity and defect perspective10.1002/pssc.200672164 ↗
31. The identification of hydroxyl groups on ZnO nanoparticles by infrared spectroscopy10.1039/b811029h ↗
32. Mayo · 2004
33. Preparation, characterization and surface morphology of novel optically active poly(ester-amide)/functionalized ZnO bionanocomposites via ultrasonication assisted process10.1016/j.apsusc.2011.02.112 ↗
34. Doxorubicin-wrapped zinc oxide nanoclusters for the therapy of colorectal adenocarcinoma10.3390/nano7110354 ↗
35. Degradation of reactive dye using heterogeneous photo-Fenton catalysts: ZnFe2O4 and GO-ZnFe2O4 composite10.1088/2053-1591/ab66ee ↗
36. One-pot hydrothermal synthesis of Zinc ferrite/reduced graphene oxide as an efficient electrocatalyst for oxygen reduction reaction10.1016/j.jcis.2016.04.035 ↗
37. Unexpected behavior of copper in modified ferrites during high temperature WGS Reaction aspects of Fe3+↔ Fe2+ redox chemistry from Mössbauer and XPS studies10.1021/jp301090d ↗
38. XPS photoemission in carbonaceous materials: a “defect” peak beside the graphitic asymmetric peak10.1016/j.carbon.2004.03.005 ↗
39. The role of Ga substitution on magnetic and electromagnetic properties of nano-sized W-type hexagonal ferrites10.1016/j.cap.2012.06.014 ↗
40. Effects of various sintering conditions on the structural and magnetic properties of zinc ferrite (ZnFe2O4)10.1590/1980-5373-mr-2020-0300 ↗
41. Investigations on dielectric and impedance properties of M-type hexaferrite10.1007/s10854-016-5876-4 ↗
42. Manipulating electronic structure of graphene for producing ferromagnetic graphene particles by Leidenfrost effect-based method10.1038/s41598-020-63478-7 ↗
43. Superparamagnetic graphene oxide/magnetite nanocomposite delivery system for doxorubicin-induced distinguished tumor cell cycle arrest and apoptosis10.1007/s11051-020-04932-5 ↗
44. Synthesis and characterization of zinc ferrite by XRD, VSM and electron spin resonance techniques10.1142/S021797921250213X ↗
45. Characterization of magnetic phases in nanostructured ferrites by electron spin resonance
46. Fullerene as a doxorubicin nanotransporter for targeted breast cancer therapy: capillary electrophoresis analysis10.1002/elps.201800148 ↗
47. Graphene-based nanomaterials for drug and/or gene delivery, bioimaging, and tissue engineering10.1016/j.drudis.2017.04.002 ↗
48. Zinc ferrite nanoparticles activate IL-1b, NFKB1, CCL21 and NOS2 signaling to induce mitochondrial dependent intrinsic apoptotic pathway in WISH cells10.1016/j.taap.2013.09.001 ↗
49. Mitochondrial dysfunction, autophagy stimulation and non-apoptotic cell death caused by nitric oxide-inducing Pt-coated Au nanoparticle in human lung carcinoma cells10.1016/j.bbagen.2019.129452 ↗
50. Zinc oxide nanoparticles induce human multiple myeloma cell death via reactive oxygen species and Cyt-C/Apaf-1/Caspase-9/Caspase-3 signaling pathway in vitro10.1016/j.biopha.2019.109712 ↗
51. Chitosan mediated gold nanoparticles against pathogenic bacteria, fungal strains and MCF-7 cancer cells10.1016/j.ijbiomac.2020.01.037 ↗
52. Neurotoxicity mediated by oxidative stress caused by titanium dioxide nanoparticles in human neuroblastoma (SH-SY5Y) cells10.1016/j.jtemb.2019.126413 ↗
53. In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells
54. Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells10.1186/1743-8977-7-10 ↗
55. Mechanistic insights into the release of doxorubicin from graphene oxide in cancer cells10.3390/nano10081482 ↗
56. Unraveling the interaction between doxorubicin and DNA origami nanostructures for customizable chemotherapeutic drug release10.1093/nar/gkab097 ↗
57. Cytotoxicity of nickel zinc ferrite nanoparticles on cancer cells of epithelial origin10.2147/IJN.S42367 ↗
58. Multifunctional graphene oxide/iron oxide nanoparticles for magnetic targeted drug delivery dual magnetic resonance/fluorescence imaging and cancer sensing10.1371/journal.pone.0217072 ↗
59. Core/shell Fe 3 O 4/Gd 2 O 3 nanocubes as T 1–T 2 dual modal MRI contrast agents10.1039/C6NR02620F ↗
60. Octapod iron oxide nanoparticles as high-performance T(2) contrast agents for magnetic resonance imaging10.1038/ncomms3266 ↗
61. Multidentate catechol-based polyethylene glycol oligomers provide enhanced stability and biocompatibility to iron oxide nanoparticles10.1021/nn203735b ↗
62. The roles of morphology on the relaxation rates of magnetic nanoparticles10.1021/acsnano.8b01048 ↗
63. Cobalt zinc ferrite nanoparticles as a potential magnetic resonance imaging agent: an in vitro study
64. A synergistically enhanced T1–T2 dual‐modal contrast agent10.1002/adma.201203169 ↗
65. Smart" theranostic lanthanide nanoprobes with simultaneous up-conversion fluorescence and tunable T1-T2 magnetic resonance imaging contrast and near-infrared activated photodynamic therapy10.1039/C4NR01717J ↗
66. Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging10.1002/adhm.201200340 ↗
67. Magnetic nanoscale metal organic frameworks for potential targeted anticancer drug delivery, imaging and as an MRI contrast agent10.1039/C5DT03736K ↗